Search

everythinglearnresearchcommunity

for

Search:↓

The protein StAR is found in 17 different organs and can affect hair loss and brain functions, but its full role is not yet fully understood.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Wounds heal without scarring in early development but later result in scars, and studying Wnt signaling could help control scarring.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

Supercritical CO2 extraction makes rice bran oil healthier and safer than traditional methods.

Low-glycemic index diets are beneficial for weight loss and satiety, but more research is needed on long-term effects and individualized approaches are recommended.

Women with PCOS have more severe liver disease.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

People with alopecia are at higher risk for heart disease and have more heart-related risk factors.

Women with PCOS are more likely to have fatty liver disease, especially if they have metabolic problems.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Low-dose flutamide helps reduce excessive hair growth and is even more effective with birth control, without bad effects on blood fats.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

People with Lichen Planus, especially with mucosal involvement, are more likely to have Metabolic Syndrome, which increases their risk for heart disease and diabetes.

Men with early-onset baldness have a higher chance of heart disease and clogged arteries.

The Polish medical societies have redefined metabolic syndrome and recommend lifestyle changes, certain medications, and possibly bariatric surgery for treatment. They also discuss managing related health conditions.

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.

Mutations in the NR3C1 gene cause a rare condition that affects hormone signaling and can lead to various symptoms, with dexamethasone as a treatment option.

Premature hair greying may indicate a higher risk of metabolic problems.

Long-term anabolic steroid use can lead to heart and metabolic health issues.

PCOS in lean women is a serious health condition with implications beyond fertility, affecting metabolism and increasing cardiovascular disease risk.

Early hair loss may predict heart disease.

Finasteride may lower cholesterol and slow heart disease progression.

Higher Alarin levels may predict androgenetic alopecia and metabolic syndrome.

Hair loss may increase heart disease risk.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

The supplement with Myo-inositol and D-chiro-inositol improves metabolic symptoms in PCOS, especially when combined with metformin.

Certain genetic mutations can lower bad cholesterol and reduce heart disease risk, leading to effective cholesterol-lowering drugs.